Andy Leaver

Andy Leaver is a Partner and Chairman at Fullbrook Thorpe Investments. Andy has a strong track record of building and developing pharmaceutical businesses. Andy founded the pharmaceuticals company Clinigen in 2010 which floated on the AIM market in September 2012 and was hailed as one of the best stock market launches of the year. Starting out as a supplier of medicines for clinical trials, the company quickly developed into a global provider of specialist pharmaceutical products and services. This success provides valuable experience and insights for growing businesses, particularly in product development, acquisitions, and international expansion.